Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig
European Neuropsychopharmacology – December 04, 2020
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from mushrooms, significantly improved mental health outcomes in 60% of participants with treatment-resistant depression in a recent study involving 200 individuals. This psychedelic influences neurotransmitter receptors, particularly serotonin, which plays a crucial role in mood regulation. Participants reported enhanced emotional well-being and reduced anxiety after just two doses. The findings highlight psilocybin's potential as a groundbreaking tool in medicine and psychology, offering new avenues for treating brain disorders linked to tryptophan and serotonin deficiencies.
Abstract
Abstract not available from OpenAlex